Follow-The-Filings

Security · featured owners

IRWD Ironwood Pharmaceuticals Inc.

Health Care COM CL A Equity as of 2026 Q2 among managers we track

  • 1 exit

IRWD (Ironwood Pharmaceuticals Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 13,000 $46K History

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 14 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K/A 5.02 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 8.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 Filing Doc
4 Period Jul 20, 2026 Filing Doc
4 Period Jul 7, 2026 Filing Doc
4 Period Jun 16, 2026 · 2 forms Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 16, 2026 · 4 forms Filing Doc
4 Period May 19, 2026 Filing Doc
4 Period Mar 13, 2026 Filing Doc
4 Period Mar 10, 2026 · 6 forms Filing Doc
4 Period Feb 23, 2026 · 6 forms Filing Doc
4 Period Jan 5, 2026 Filing Doc

Updated 12 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $442.74M $351.41M $296.15M
Net income -$1B $0.001B $0.024B
Net margin * -226.4% 0.3% 8.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $233.29M $182.37M $274.18M
Total non-current assets * $237.78M $168.54M $122.72M
Total assets $471.07M $350.91M $396.9M
Total current liabilities $276.1M $38.85M $242.22M
Total equity -$346.3M -$301.34M -$261.84M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $183.43M $103.55M $127.04M
Cash from investing -$1.03B -$0B -$0B
Cash from financing $277.16M -$106.97M $0.216M
Net change in cash -$565.78M -$3.6M $126.9M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders